Schwarzkopf, Daniel
Matthaeus-Kraemer, Claudia Tanja
Thomas-Rüddel, Daniel O.
Rüddel, Hendrik
Poidinger, Bernhard
Bach, Friedhelm
Gerlach, Herwig
Gründling, Matthias
Lindner, Matthias
Scheer, Christian
Simon, Philipp
Weiss, Manfred
Reinhart, Konrad
Bloos, Frank
Marx, Gernot
Schindler, Achim
Schürholz, Tobias
Schlegel‑Höfner, Heike
Lehmann, Gunther
Sander, Annett
Friese, Steffen
Scholz, Christian
Fischer, Pia
Fuchs, Christina
Becher, Lutz
Salewsky, Norbert
Schreiber, Torsten
Goldmann, Anton
Keh, Didier
Schmid, Katrin
Menning, Winfried
Steuckart, Renate
Barz, Robert
Dey, Karin
Fahrenholz, Meike
Müller, Martin
Toussaint, Susanne
Brederlau, Jörg
Buschmann, Dirk
Gummelt, Ingo
Hoeschen, J.
Klaproth, Marion
Vedder, Ina
Bachmann‑Holdau, Ulrike
Eiche, Jürgen
Hauschild, Rolf
Lange, Martina
Herrmann‑Karbaum, Davia
Lubasch, Annette
Rücker, Marcus
Icke, Christian
Lucht, Alexander
Meier‑Hellmann, Andreas
Wagner, Jan
Arnold, Olaf
Kästner, Steffen
Clausen, Tobias
Sternkopf, Michael
Voswinckel, Robert
Benndorf, T.
Eiserloh, Christel
Kuhnle, Gerhard
Koch, Mathias
Gerber, Manuela
Guderian, Liane
Kuhn, Sven‑Olaf
Scheiber, Gerd
Bloos, Frank
D’Aria, Stefanie
Lemke, Thees
Michaelsen, Birgit
Schädler, Dirk
Schulz‑Ruhtenberg, Nina
Weiler, Norbert
Anetseder, Martin
Textor, Zoran
Kaisers, Udo
Löbe, Matthias
Meineke, Frank
Pausch, Christine
Engel, Christoph
Braun, Georg
Jensen, Nicole
Gegenfurtner, Werner
Meinhardt, Alexander
Schmitt, Robert
Teichert, Andrea
Becker, Klaus‑Dieter
Diers, Anja
Jelschen, Florian
Weyland, Andreas
Knebel, Frieder
Kupfer, Thomas
Sinz, Rüdinger
Bautz, Petra
Fischer, Annemarie
Seibel, Armin
Fleischhacker, Christoph
Häberle, Helene
Henn, Philipp
Mezger, Friederike
Rosenberger, Peter
Riessen, Reimer
Ziegler, Silvia
Barth, Eberhard
Bracht, Hendrik
Heymann, I.
Hinder, A.
Sens, R.
Lascho, Christof
Micke, Henriette
Schmidt, Falk
Schilling, Stefanie
Wöbker, Gabriele
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
A multifaceted educational intervention improved anti-infectious measures but had no effect on mortality in patients with severe sepsis
https://doi.org/10.1038/s41598-022-07915-9
Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial
https://doi.org/10.1186/s13054-022-03901-9
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (FKZ 01EO1002)
Universitätsklinikum Jena
Article History
Received: 4 September 2021
Accepted: 28 February 2022
First Online: 10 March 2022
Competing interests
: Dr. Schwarzkopf has nothing to disclose. Dr. Matthäus-Krämer has nothing to disclose. Dr. Thomas-Rüddel reports grants from BMBF, outside the submitted work. Dr. Rüddel has nothing to disclose. Dr. Poidinger has nothing to disclose. Dr. Bach has nothing to disclose. Dr. Gerlach has nothing to disclose. Dr. Gründling reports grants from BMBF, outside the submitted work. Dr. Lindner has nothing to disclose. Dr. Scheer has nothing to disclose. Dr. Simon reports personal fees from InfectoPharm, outside the submitted work. Dr. Weiss has nothing to disclose. Dr. Reinhart is shareholder with less of 0.5% of InflaRx NV a Jena /Germany based Biotech Company that evaluates a immunmodulatory approach for the adjunctive treatment of COVID-19. Dr. Bloos reports grants from German Federal Ministry of Education and Research, during the conduct of the study; personal fees from Baxter, outside the submitted work.